Yi Sang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- Circular RNAs in diseases
- Ubiquitin and proteasome pathways
- DNA Repair Mechanisms
Papers in
-
- Epigenetics and DNA Methylation 13
- RNA modifications and cancer 12
- Cancer-related gene regulation 6
- DNA Repair Mechanisms 3
-
- MicroRNA in disease regulation 9
- Cancer-related molecular mechanisms research 6
- Co-authors
- Tiebang Kang (14 shared papers)Chun Cheng (8 shared papers)Kaishun Hu (8 shared papers)Jianjun Tang (9 shared papers)Guofu Huang (7 shared papers)Siwei Li (5 shared papers)Ruhua Zhang (8 shared papers)Yi-Xin Zeng (5 shared papers)
- Journals
- Oncotarget (3 papers)Scientific Reports (3 papers)Oncogene (2 papers)The Journal of Pathology (2 papers)Journal of Cellular Physiology (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Yi Sang
42 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 78
- Cancer Research 374
- Molecular Biology 767
- Geriatrics and Gerontology 32
- Oncology 180
- Immunology 90
Countries citing papers authored by Yi Sang
This map shows the geographic impact of Yi Sang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Sang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Sang more than expected).
Fields of papers citing papers by Yi Sang
This network shows the impact of papers produced by Yi Sang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Sang. The network helps show where Yi Sang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Sang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 97 | |
| 2 | 2012 | 97 | |
| 3 | 2015 | 77 | |
| 4 | 2020 | 69 | |
| 5 | 2016 | 66 | |
| 6 | 2016 | 57 | |
| 7 | 2012 | 55 | |
| 8 | 2013 | 53 | |
| 9 | 2016 | 47 | |
| 10 | 2014 | 46 | |
| 11 | 2011 | 45 | |
| 12 | 2021 | 40 | |
| 13 | 2015 | 36 | |
| 14 | 2021 | 33 | |
| 15 | 2013 | 30 | |
| 16 | miR-148b functions as a tumor suppressor in non-small cell lung cancer by targeting carcinoembryonic antigen (CEA). | 2014 | 29 |
| 17 | 2021 | 28 | |
| 18 | 2015 | 21 | |
| 19 | 2018 | 20 | |
| 20 | 2020 | 18 |
About Yi Sang
Yi Sang is a scholar working on Molecular Biology, Cancer Research, Oncology, Pathology and Forensic Medicine and Immunology, having authored 44 papers that have together received 1.1k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (13 papers), RNA modifications and cancer (12 papers), MicroRNA in disease regulation (9 papers), Cancer-related gene regulation (6 papers), Cancer-related molecular mechanisms research (6 papers), DNA Repair Mechanisms (3 papers), interferon and immune responses (3 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Cancer Research (374 citations), Molecular Biology (767 citations), Geriatrics and Gerontology (32 citations), Oncology (180 citations) and Immunology (90 citations). Yi Sang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Tiebang Kang, Chun Cheng, Kaishun Hu, Jianjun Tang, Guofu Huang, Siwei Li, Ruhua Zhang, Yi-Xin Zeng, Lijuan Liu and Yuanzhong Wu. Their work appears in journals such as Oncotarget, Scientific Reports, Oncogene, The Journal of Pathology and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.